{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T14:17:01Z","timestamp":1758637021543,"version":"3.37.3"},"reference-count":37,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National High Technology Research and Development Program of China","award":["2012AA021008"],"award-info":[{"award-number":["2012AA021008"]}]},{"DOI":"10.13039\/501100005890","name":"Ministry of Health","doi-asserted-by":"publisher","award":["2010159","201002004"],"award-info":[{"award-number":["2010159","201002004"]}],"id":[{"id":"10.13039\/501100005890","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and Technology Planning Key Clinical Project of Guangdong Province","award":["2011A030400005"],"award-info":[{"award-number":["2011A030400005"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.transproceed.2018.01.059","type":"journal-article","created":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T21:55:12Z","timestamp":1545083712000},"page":"3356-3360","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Conversion From Mycophenolates to Mizoribine Is Associated With\u00a0Lower BK Virus Load in Kidney Transplant Recipients: A\u00a0Prospective Study"],"prefix":"10.1016","volume":"50","author":[{"given":"X.","family":"Yuan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 4","key":"10.1016\/j.transproceed.2018.01.059_bib1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/ajt.12110","article-title":"BK polyomavirus in solid organ transplantation","volume":"13","author":"Hirsch","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2018.01.059_bib2","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1097\/01.TP.0000156165.83160.09","article-title":"Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations","volume":"79","author":"Hirsch","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2018.01.059_bib3","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/MOT.0000000000000101","article-title":"BK virus infection following kidney transplantation: an overview of risk factors, screening strategies, and therapeutic interventions","volume":"19","author":"Pham","year":"2014","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.transproceed.2018.01.059_bib4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.idc.2013.02.002","article-title":"BK polyomavirus infection in the renal transplant recipient","volume":"27","author":"Balba","year":"2013","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.transproceed.2018.01.059_bib5","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/TP.0b013e31828423cd","article-title":"Screening for BK viremia reduces but does not eliminate the risk of BK nephropathy: a single-center retrospective analysis","volume":"95","author":"Knight","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2018.01.059_bib6","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/TP.0b013e31819cc383","article-title":"An OPTN analysis of national registry data on treatment of BK virus allograft nephropathy in the United States","volume":"87","author":"Dharnidharka","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2018.01.059_bib7","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1128\/JCM.00655-07","article-title":"Monitoring of polyomavirus BK virus viruria and viremia in renal allograft recipients by use of a quantitative real-time PCR assay: one-year prospective study","volume":"45","author":"Pang","year":"2007","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.transproceed.2018.01.059_bib8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/TP.0b013e3181aa8f62","article-title":"Sustained BK viruria as an early marker for the development of BKV-associated nephropathy: analysis of 4128 urine and serum samples","volume":"88","author":"Babel","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2018.01.059_bib9","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/01.tp.0000269706.59977.a5","article-title":"Polyomavirus BK versus JC replication and nephropathy in renal transplant recipients: a prospective evaluation","volume":"84","author":"Drachenberg","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2018.01.059_bib10","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.3892\/mmr.2013.1334","article-title":"Effect of a BK viruria reaction detected by qualitative polymerase chain reaction on the renal function of kidney transplant recipients","volume":"7","author":"Hsieh","year":"2013","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.transproceed.2018.01.059_bib11","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.trim.2012.12.003","article-title":"The argument for the use of mizoribine in renal transplantation: a meta-analysis and systemic review","volume":"28","author":"Zhang","year":"2013","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.transproceed.2018.01.059_bib12","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.clinbiochem.2014.01.014","article-title":"Comparative efficacy and safety of mizoribine with mycophenolate mofetil for Asian renal transplantation\u2014a meta-analysis","volume":"47","author":"Xing","year":"2014","journal-title":"Clin Biochem"},{"key":"10.1016\/j.transproceed.2018.01.059_bib13","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.transproceed.2015.12.117","article-title":"Efficacy and safety of high-dose mizoribine combined with cyclosporine, basiliximab, and corticosteroids in renal transplantation: a Japanese multicenter study","volume":"48","author":"Ushigome","year":"2016","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2018.01.059_bib14","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/j.transproceed.2013.01.055","article-title":"Excellent results of high-dose mizoribine combined with cyclosporine, basiliximab, and corticosteroids in renal transplant recipients\u20144-year results","volume":"45","author":"Yoshimura","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2018.01.059_bib15","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1124\/jpet.109.160630","article-title":"Novel anticytomegalovirus activity of immunosuppressant mizoribine and its synergism with ganciclovir","volume":"333","author":"Kuramoto","year":"2010","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.transproceed.2018.01.059_bib16","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.bbrc.2005.03.062","article-title":"Mizoribine inhibits hepatitis C virus RNA replication: effect of combination with interferon-alpha","volume":"330","author":"Naka","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.transproceed.2018.01.059_bib17","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1517\/13543784.9.2.221","article-title":"Recent progress in antiviral chemotherapy for respiratory syncytial virus infections","volume":"9","author":"Shigeta","year":"2000","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.transproceed.2018.01.059_bib18","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1177\/095632020201300602","article-title":"Inhibitors of the IMPDH enzyme as potential anti-bovine viral diarrhoea virus agents","volume":"13","author":"Stuyver","year":"2002","journal-title":"Antivir Chem Chemother"},{"key":"10.1016\/j.transproceed.2018.01.059_bib19","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/infdis\/168.3.641","article-title":"Comparative inhibitory effects of various nucleoside and nonnucleoside analogues on replication of influenza virus types A and B in\u00a0vitro and in\u00a0ovo","volume":"168","author":"Hosoya","year":"1993","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.transproceed.2018.01.059_bib20","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1016\/j.transproceed.2008.07.069","article-title":"Conversion from mycophenolate mofetil to mizoribine for patients with positive polyomavirus type BK in urine","volume":"40","author":"Funahashi","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2018.01.059_bib21","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.diagmicrobio.2012.11.012","article-title":"Noninvasive tool for the diagnosis of polyomavirus BK-associated nephropathy in renal transplant recipients","volume":"75","author":"Huang","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.transproceed.2018.01.059_bib22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.diagmicrobio.2014.09.024","article-title":"Monitoring of polyomavirus BK replication and impact of preemptive immunosuppression reduction in renal-transplant recipients in China: a 5-year single-center analysis","volume":"81","author":"Huang","year":"2015","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.transproceed.2018.01.059_bib23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1399-3062.2011.00619.x","article-title":"Monthly screening for BK viremia is an effective strategy to prevent BK virus nephropathy in renal transplant recipients","volume":"13","author":"Almeras","year":"2011","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.transproceed.2018.01.059_bib24","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1055\/s-0033-1341499","article-title":"Determination of mizoribine in human plasma using high-performance liquid chromatography: application to a pharmacokinetic study in Chinese renal transplant recipients","volume":"63","author":"Ren","year":"2013","journal-title":"Drug Res (Stuttg)"},{"key":"10.1016\/j.transproceed.2018.01.059_bib25","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S0046-8177(99)90252-6","article-title":"Human polyoma virus in renal allograft biopsies: morphological findings and correlation with urine cytology","volume":"30","author":"Drachenberg","year":"1999","journal-title":"Hum Pathol"},{"key":"10.1016\/j.transproceed.2018.01.059_bib26","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/ajt.14107","article-title":"The Banff 2015 Kidney Meeting Report: current challenges in rejection classification and prospects for adopting molecular pathology","volume":"17","author":"Loupy","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2018.01.059_bib27","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1600-6143.2005.00742.x","article-title":"Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction","volume":"5","author":"Brennan","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2018.01.059_bib28","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1111\/j.1600-6143.2010.03310.x","article-title":"Reducing immunosuppression preserves allograft function in presumptive and definitive polyomavirus-associated nephropathy","volume":"10","author":"Schaub","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2018.01.059_bib29","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/tid.12603","article-title":"Preemptive reduction of immunosuppression upon high urinary polyomavirus loads improves patient survival without affecting kidney graft function","volume":"18","author":"Broeders","year":"2016","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.transproceed.2018.01.059_bib30","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1097\/TP.0b013e3182921995","article-title":"Risk factors for BK virus infection in the era of therapeutic drug monitoring","volume":"95","author":"Borni-Duval","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2018.01.059_bib31","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1600-6143.2012.04320.x","article-title":"Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study","volume":"13","author":"Hirsch","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2018.01.059_bib32","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1097\/TP.0b013e31816a33d4","article-title":"Does reduction in immunosuppression in viremic patients prevent BK virus nephropathy in de novo renal transplant recipients? A prospective study","volume":"85","author":"Almeras","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2018.01.059_bib33","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1600-6143.2009.02952.x","article-title":"BK-virus and the impact of pre-emptive immunosuppression reduction: 5-year results","volume":"10","author":"Hardinger","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2018.01.059_bib34","first-page":"1682","article-title":"Effects of cyclosporine, azathioprine, mizoribine, and prednisolone on replication of human cytomegalovirus","volume":"22","author":"Shiraki","year":"1990","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2018.01.059_bib35","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s10157-012-0669-4","article-title":"The beneficial effect of high-dose mizoribine combined with cyclosporine, basiliximab, and corticosteroids on CMV infection in renal transplant recipients","volume":"17","author":"Yoshimura","year":"2013","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.transproceed.2018.01.059_bib36","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.transproceed.2012.10.030","article-title":"Influence of serum uric acid levels in response to the conversion from mycophenolate mofetil to mizoribine in kidney transplant recipients","volume":"45","author":"Ding","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2018.01.059_bib37","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1016\/j.transproceed.2010.05.148","article-title":"Acute allograft renal failure with marked hyperuricemia developing during mizoribine administration: a case report with review of the literature","volume":"42","author":"Guo","year":"2010","journal-title":"Transplant Proc"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134518302616?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134518302616?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T03:42:33Z","timestamp":1565235753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134518302616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0041134518302616"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2018.01.059","relation":{},"ISSN":["0041-1345"],"issn-type":[{"type":"print","value":"0041-1345"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Conversion From Mycophenolates to Mizoribine Is Associated With\u00a0Lower BK Virus Load in Kidney Transplant Recipients: A\u00a0Prospective Study","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2018.01.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}